Cargando…
The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions
AIM: We aimed to evaluate the 1-year efficacy and safety of low-frequency intravitreal bevacizumab in the treatment of macular edema due to retinal vein occlusions (RVOs). METHODS: The study comprised an interventional prospective study of patients with macular edema due to central retinal vein occl...
Autores principales: | Ivanovska Adjievska, Biljana, Boskurt, Salih, Orovcanec, Nikola, Dimovska-Jordanova, Vesna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488787/ https://www.ncbi.nlm.nih.gov/pubmed/28790803 http://dx.doi.org/10.2147/OPTH.S137380 |
Ejemplares similares
-
Treatment of idiopathic macular hole with silicone oil tamponade
por: Ivanovska-Adjievska, Biljana, et al.
Publicado: (2012) -
Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
por: Gutiérrez, Juan Carlos Mesa, et al.
Publicado: (2008) -
Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results
por: Demir, Mehmet, et al.
Publicado: (2011) -
Grid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion
por: Ogino, Ken, et al.
Publicado: (2011) -
Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results
por: Thapa, Raba, et al.
Publicado: (2012)